Diflunisal Offlabel denied for missing prior authorization by Humana?

Humana's specific coverage criteria for diflunisal offlabel are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Humana Requires Prior Authorization for Off-Label Diflunisal

When diflunisal is prescribed for an indication outside its FDA-approved labeling — such as for amyloid-related conditions — Humana classifies it as a non-standard use requiring prior authorization (PA) before dispensing. A denial for "prior auth required" typically means either that no PA was submitted, or that a submitted PA was denied because the documentation did not satisfy Humana's review criteria.

## Why This Is Appealable

A PA denial is a coverage decision and carries full appeal rights. Humana cannot require PA as an unreviewable gatekeeping step — if the PA is denied, you are entitled to know the specific criteria that were not met, and you have the right to challenge that finding with additional clinical evidence. If a PA was never submitted, the prescriber can initiate one; if it was denied, you should appeal rather than abandon the request.

## Federal Appeal Framework

• Internal appeal: File within 180 days of the denial. For prospective (pre-service) PA denials, Humana must respond within 15 days for standard review and 72 hours for urgent/expedited requests.
• External review (ACA §2719): After exhausting internal appeals, you may request independent external review within 4 months of the final denial. The IRO decision is binding on Humana.
• ERISA §503 (self-funded plans): Self-funded employer plans must provide a full-and-fair review process, and federal courts may review procedural failures.
• Expedited review: Available when a standard timeline could seriously harm your health — request it explicitly in writing.

## Documentation to Gather

1. Complete PA package — the original PA submission, the denial letter (with the specific criteria cited), and any correspondence. 2. Prescriber medical-necessity letter — a detailed clinical narrative explaining the diagnosis, why this drug is appropriate, what alternatives have been considered, and why they are unsuitable or have failed. 3. Diagnosis records — imaging, pathology, genetic testing, or specialist evaluation confirming the condition. 4. Prior treatment history — a dated list of all therapies tried, doses used, duration, and the documented reason each was stopped or was insufficient. 5. Clinical severity notes — functional assessments, symptom scoring, and objective measures from the chart.

## Criteria-Mapping Structure

Obtain Humana's current prior-authorization criteria document for this drug and indication from Humana's provider or member portal. Copy each criterion and document how your case satisfies it:

| PA Criterion (from Humana's policy) | Evidence in Your Chart | |---|---| | Confirmed qualifying diagnosis | [Attach report] | | Prescriber specialty or attestation | [Specialist note] | | Step therapy or alternative treatments tried | [Dated treatment log] | | Supporting clinical evidence for off-label use | [Literature / compendia cite] |

The exact criteria are what control your appeal — always pull the live policy before submitting.